antiviral polymerase inhibitors (Shanghai Target Drug)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantiviral polymerase inhibitors (Shanghai Target Drug)
Drug Alias Nameantiviral inhibitors (TargetDrug/Avexa)antiviral polymerase inhibitors (Shanghai Target Drug/Avexa)antiviral replication inhibitors (Shanghai Target Drug/Avexa)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase modulators
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Targetdrug Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTali Digital LtdShanghai Targetdrug Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A